TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/3/24 16:11 | 12/29/23 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Oelschlager Kristen M | TX | O | COO | M.d | 38 | 3.01 | 0 | 13 | 9 | 150 | D | ||||||||||||||
12/12/23 19:39 | 12/9/23 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Oelschlager Kristen M | TX | O | COO | M.dm | 0 | 0.00 | 0 | 24 | 21 | 138 | D | ||||||||||||||
12/30/22 16:37 | 12/28/22 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Oelschlager Kristen M | TX | O | COO | M.d | 17 | 2.39 | 0 | 7 | 6 | 119 | D | ||||||||||||||
12/13/22 16:39 | 12/10/22 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Oelschlager Kristen M | TX | O | COO | M.d | 0 | 0.00 | 0 | 8 | 8 | 112 | D | ||||||||||||||
12/14/21 19:58 | 12/10/21 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Oelschlager Kristen M | TX | O | COO | M.d | 0 | 0.00 | 0 | 2 | 2 | 99 | D | ||||||||||||||
9/29/21 16:07 | 9/27/21 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Oelschlager Kristen M | TX | O | COO | S | -710 | 71.02 | 0 | -10 | -9 | 98 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |